NO305835B1 - Aralkyltiadiazinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler - Google Patents

Aralkyltiadiazinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler

Info

Publication number
NO305835B1
NO305835B1 NO960352A NO960352A NO305835B1 NO 305835 B1 NO305835 B1 NO 305835B1 NO 960352 A NO960352 A NO 960352A NO 960352 A NO960352 A NO 960352A NO 305835 B1 NO305835 B1 NO 305835B1
Authority
NO
Norway
Prior art keywords
aralkylthiadiazinone
pharmaceuticals
derivatives
compounds
manufacture
Prior art date
Application number
NO960352A
Other languages
English (en)
Other versions
NO960352D0 (no
NO960352L (no
Inventor
Rochus Jonas
Michael Wolf
Michael Klockow
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO960352D0 publication Critical patent/NO960352D0/no
Publication of NO960352L publication Critical patent/NO960352L/no
Publication of NO305835B1 publication Critical patent/NO305835B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO960352A 1995-01-28 1996-01-26 Aralkyltiadiazinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler NO305835B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19502699A DE19502699A1 (de) 1995-01-28 1995-01-28 Arylalkyl-thiadiazinone

Publications (3)

Publication Number Publication Date
NO960352D0 NO960352D0 (no) 1996-01-26
NO960352L NO960352L (no) 1996-07-29
NO305835B1 true NO305835B1 (no) 1999-08-02

Family

ID=7752553

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960352A NO305835B1 (no) 1995-01-28 1996-01-26 Aralkyltiadiazinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler

Country Status (22)

Country Link
US (2) US5747489A (no)
EP (1) EP0723962B1 (no)
JP (1) JP3878237B2 (no)
KR (1) KR100384726B1 (no)
AT (1) ATE202775T1 (no)
AU (1) AU705639B2 (no)
CA (1) CA2168193C (no)
CZ (1) CZ286635B6 (no)
DE (2) DE19502699A1 (no)
DK (1) DK0723962T3 (no)
ES (1) ES2160184T3 (no)
GR (1) GR3036343T3 (no)
HU (1) HU219361B (no)
NO (1) NO305835B1 (no)
PL (1) PL184486B1 (no)
PT (1) PT723962E (no)
RU (1) RU2161613C2 (no)
SI (1) SI0723962T1 (no)
SK (1) SK281052B6 (no)
TW (1) TW342389B (no)
UA (1) UA42731C2 (no)
ZA (1) ZA96630B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514568A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
CA2437932A1 (en) * 2001-02-12 2002-09-19 Merck Patent Gesellschaft Mit Beschraenkter Haftung Use of type 4 phosphodiesterase inhibitors in myocardial diseases
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
CZ2004516A3 (cs) * 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
EP1716123A1 (en) * 2004-02-04 2006-11-02 Altana Pharma AG Pyridazinone derivatives and their use as pde4 inhibitors
US7494990B2 (en) 2004-02-04 2009-02-24 Nycomed Gmbh 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
DE102005055355A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate
DE102005055354A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
US8418387B2 (en) * 2009-11-13 2013-04-16 Manufacturing Resources International, Inc. Isolated access assembly for back-to-back electronic display and static display
RU2597764C2 (ru) * 2014-12-16 2016-09-20 Федеральное государственное автономное образовательное учреждение высшего образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" Применение соединений класса 1,3,4-тиадиазина в качестве средства коррекции экспериментального аллоксанового сахарного диабета
RU2659574C2 (ru) * 2016-12-27 2018-07-05 федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) 6-(3,5-Дифенил-1,3,4-тиадиазол-2(3Н)-илиден)-2,4-дифенил-4Н-1,3,4-тиадиазин-5-он и способ его получения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
DE3719031A1 (de) * 1987-06-06 1988-12-22 Merck Patent Gmbh 5-(1,2,3,4-tetrahydrochinolyl)-3,6-dihydro-1,3,4-thiadiazin-2-one
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone

Also Published As

Publication number Publication date
CA2168193C (en) 2006-08-15
CZ286635B6 (cs) 2000-05-17
DK0723962T3 (da) 2001-10-29
KR960029327A (ko) 1996-08-17
US6025354A (en) 2000-02-15
SK281052B6 (sk) 2000-11-07
ES2160184T3 (es) 2001-11-01
ZA96630B (en) 1996-08-15
TW342389B (en) 1998-10-11
RU2161613C2 (ru) 2001-01-10
US5747489A (en) 1998-05-05
NO960352D0 (no) 1996-01-26
GR3036343T3 (en) 2001-11-30
ATE202775T1 (de) 2001-07-15
HU219361B (en) 2001-03-28
JPH08231522A (ja) 1996-09-10
EP0723962A1 (de) 1996-07-31
JP3878237B2 (ja) 2007-02-07
PL184486B1 (pl) 2002-11-29
AU705639B2 (en) 1999-05-27
NO960352L (no) 1996-07-29
CA2168193A1 (en) 1996-07-29
CZ25196A3 (en) 1996-08-14
DE19502699A1 (de) 1996-08-01
KR100384726B1 (ko) 2003-08-25
PT723962E (pt) 2001-10-31
UA42731C2 (uk) 2001-11-15
PL312489A1 (en) 1996-08-05
HUT73981A (en) 1996-10-28
HU9503933D0 (en) 1996-03-28
SK12396A3 (en) 1996-10-02
SI0723962T1 (no) 2001-12-31
EP0723962B1 (de) 2001-07-04
DE59607188D1 (de) 2001-08-09
AU4211196A (en) 1996-08-08

Similar Documents

Publication Publication Date Title
NO305835B1 (no) Aralkyltiadiazinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
NO305365B1 (no) Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter
NO305246B1 (no) Oksazolidinonforbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
DK78995A (da) Anvendelse af visse substituerede arylalkylaminer til fremstilling af et lægemiddel med neurobeskyttende virkning
NO305901B1 (no) Alkylbenzoylguanidiner, farmasöytiske preparater som inneholder minst en slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
IL115028A0 (en) Cyclohexadiene derivatives their pharmaceutical compositions containing them
IL119054A0 (en) Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
AR041131A1 (es) Derivados de aminoindazol utilizados como medicamentos y composiciones farmaceuticas que los contienen
ES2152459T3 (es) Aminopiranos sustituidos con acilo con actividad moduladora sobre canales de potasio.
HUP9903968A2 (hu) Nem-peptid bombezin receptor antagonisták és alkalmazásuk